BioLife Solutions, Inc. Discontinued Operation, Tax Effect of Discontinued Operation
BioLife Solutions, Inc. (BLFS) reported Discontinued Operation, Tax Effect of Discontinued Operation of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation · last filed 2026-08-06
- BioLife Solutions, Inc. discontinued operation, tax effect of discontinued operation for the quarter ending 2026-06-30 was $0.00.
- BioLife Solutions, Inc. discontinued operation, tax effect of discontinued operation for the quarter ending 2026-03-31 was $0.00.
- BioLife Solutions, Inc. discontinued operation, tax effect of discontinued operation for the quarter ending 2025-12-31 was $0.00.
- BioLife Solutions, Inc. discontinued operation, tax effect of discontinued operation for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- BioLife Solutions, Inc. discontinued operation, tax effect of discontinued operation for fiscal 2025 was $0.00.
- BioLife Solutions, Inc. discontinued operation, tax effect of discontinued operation for fiscal 2024 was -$132.00K.
- BioLife Solutions, Inc. discontinued operation, tax effect of discontinued operation for fiscal 2023 was -$233.00K, a 208.88% decline from fiscal 2022.
- BioLife Solutions, Inc. discontinued operation, tax effect of discontinued operation for fiscal 2022 was $214.00K.
| Period end | Discontinued Operation, Tax Effect of Discontinued Operation 3 month | Discontinued Operation, Tax Effect of Discontinued Operation 3 month as first filed | Discontinued Operation, Tax Effect of Discontinued Operation 6 month | Discontinued Operation, Tax Effect of Discontinued Operation 6 month as first filed | Discontinued Operation, Tax Effect of Discontinued Operation 9 month | Discontinued Operation, Tax Effect of Discontinued Operation 9 month as first filed | Discontinued Operation, Tax Effect of Discontinued Operation 12 month | Discontinued Operation, Tax Effect of Discontinued Operation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-05-07 | $0.00 derived: sum of 3 quarters · filed 2026-05-07 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $0.00 10-Q · filed 2025-11-06 | -$298.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | -$298.00K derived: sum of 3 quarters · filed 2026-08-06 | -$246.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | -$298.00K derived: sum of 2 quarters · filed 2026-05-07 | -$246.00K derived: sum of 3 quarters · filed 2026-05-07 | -$246.00K derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$298.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$246.00K derived: sum of 2 quarters · filed 2026-02-26 | -$246.00K derived: sum of 3 quarters · filed 2026-02-26 | -$132.00K 10-K · filed 2026-02-26 | $132.00K 10-K · filed 2025-03-03 | |||
| 2024-09-30 | $52.00K 10-Q · filed 2025-11-06 | $0.00 10-Q · filed 2024-11-12 | $52.00K derived: sum of 2 quarters · filed 2025-11-06 | $166.00K 10-Q · filed 2025-11-06 | $10.00K 10-Q · filed 2024-11-12 | -$70.00K derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | $114.00K 10-Q · filed 2025-08-07 | $10.00K 10-Q · filed 2024-08-09 | -$122.00K derived: sum of 3 quarters · filed 2026-02-26 | -$122.00K derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | $114.00K 10-Q · filed 2025-05-08 | -$122.00K derived: sum of 2 quarters · filed 2026-02-26 | -$122.00K derived: sum of 3 quarters · filed 2026-02-26 | -$119.00K derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$236.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$236.00K derived: sum of 2 quarters · filed 2026-02-26 | -$233.00K derived: sum of 3 quarters · filed 2026-02-26 | -$233.00K 10-K · filed 2026-02-26 | $193.00K 10-K · filed 2025-03-03 | |||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | $3.00K derived: sum of 2 quarters · filed 2024-11-12 | $3.00K 10-Q · filed 2024-11-12 | |||||
| 2023-06-30 | $3.00K 10-Q · filed 2024-08-09 | $3.00K 10-Q · filed 2024-08-09 | ||||||
| 2022-12-31 | $214.00K 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |